Form 4: BioLargo Executive Acquires Shares in Debt-for-Equity Swap

BioLargo's Chief Science Officer, Kenneth Reay, acquired 57,666 shares of common stock in a debt-for-equity swap, reducing the company's liabilities.

Summary

• Kenneth Reay, Chief Science Officer of BioLargo, Inc., acquired 57,666 shares of common stock on December 31, 2024.
• The shares were acquired at a price of $0.19 per share.
• This acquisition was part of a debt-for-equity swap, where the shares were issued in exchange for a reduction in amounts owed to Mr. Reay for salary and unreimbursed business expenses.
• Following the transaction, Mr. Reay beneficially owns a total of 25,120,245 shares, including 22,139,012 shares held indirectly through a wholly-owned corporation.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the transaction reduces liabilities and aligns executive interests, but it is not a major event.

Positives

• The debt-for-equity swap reduces BioLargo's liabilities.
• The transaction aligns the interests of the executive with the company's performance.

Industry Context

This type of transaction is not uncommon for companies looking to manage their liabilities and align executive interests with company performance. It is a common practice in the industry to use equity to compensate executives and reduce cash outflow.

Comparison to Industry Standards

• Debt-for-equity swaps are a common practice, especially for smaller companies or those in a growth phase, similar to other companies in the biotech and environmental technology sectors.
• The price of $0.19 per share is specific to BioLargo's valuation at the time of the transaction and would need to be compared to other similar companies to determine if it is in line with industry standards.
• The total shares owned by Kenneth Reay, including indirect holdings, is a significant stake in the company, which is not unusual for a founder or key executive.

Stakeholder Impact

• Shareholders may view the debt-for-equity swap positively as it reduces company liabilities.
• Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

Keywords

BioLargo, Kenneth Reay, debt-for-equity swap, share acquisition, insider transaction, common stock, executive compensation